RE:RE:Please Mr.GhezzholeHe pumped us up pretty good the first time and we learned. I don't think he has additional effective pumping tools in his toolchest. Audited financial statements come out once per year, and there are no indications that there is a high flyer growth rate on his current contracts so I fear some slow and steady progress without hitches would take years to hit a buck. And I would still be suffering hefty losses.
BC was $ billions. Global was over $100 million in signed contracts and was paving way for acquisitions and growth targeting $400 million within a few short years. Fast forward to today, shooting for about $20 - $25 million in revenues. With so many stocks having taken a hit due to high interest rates, is this one really the one that anyone would pick as an opportunity?
You want a shot at a microcap that is actually showing life on the business side,? TMG is a better pick (and in the clean tech space if that is why someone would like KNR). Better growth, balance sheet KNR would be envious of. And even though its SP broke out the last month or so, I suspect it is only the beginning.
What could bring KNR price up (substantially?)? We learned from one of the recent contract news releases about a couple of contracts that were worth half a million. So, with these kinds of contracts worth in the quarter million dollar range, they better start inking them on a bi-weekly basis. Ghezzi use to suggest that one should invest into KNR because management held a large position. Effectively, invest in management. Nope. I don't think this CEO, CFO and the board deserves backing of hard-working individuals' money.
Where is Yearning Yank to continue taking shots at dissatified, losing shareholders, and protect the BioCloud potential? Looks like he took his hefty losses and moved on. That must have been painful because I remember his level of dissatisfaction when the stock moved under US$1. Wow! That was a great price!